This metabolic enhancement prevents T cell exhaustion and promotes a memory‐like phenotype, significantly improving antitumor responses in adoptive T cell therapy.[93] In addition, Bezafibrate enhances PD‐1 blockade efficacy in lung cancer by promoting FAO in tumor‐infiltrating CD8+ T cells. Here, CD8A is linked to lung cancer.